<DOC>
	<DOCNO>NCT02962232</DOCNO>
	<brief_summary>To evaluate safety efficacy paclitaxel-eluting peripheral balloon dilatation catheter ( LEGFLOW ) compare PTA catheter ( AMPHIRION DEEP ) treatment stenosis occlusion arterial vasculature knee .</brief_summary>
	<brief_title>A Study Arterial Vasculature Below Knee Treated With LEGFLOW OTW</brief_title>
	<detailed_description>To evaluate safety efficacy paclitaxel-eluting peripheral balloon dilatation catheter ( LEGFLOW ) compare PTA catheter ( AMPHIRION DEEP ) .in treatment stenosis occlusion arterial vasculature knee . This prospective , multi-center , randomized , control , opening , superiority design clinical study . Plan enroll 172 eligible subject 15 center China , subject randomize 1:1 study group ( LEGFLOW OTW group , n=86 ) control group ( AMPHIRION DEEP group , n=86 ) , accept treatment LEGFLOW OTW AMPHIRION DEEP respectively .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>age 18 85 year ( include 18 85 year ) ; critical limb ischemia subject ( Rutherford classification 3 6 ) expective survival 1 year ; understand study objective , self willing enrolls sign inform consent , accept schedule follow specific time . Angiographic inclusive criterion : reference vessel diameter 2.03.5mm ; stenosis occlusion arterial vasculature knee shall distal outflow ; target lesion stenosis ≥70 % occlusion , length ≤270mm ; subject ipsilateral / contralateral iliac lesion , iliac lesion shall meet follow criterion : iliac lesion occlusion length ≤100mm shall treat earlier target lesion shall treat successfully . successful treatment standard : 1 ) residual stenosis &lt; 30 % ; 2 ) without flow limit dissection 3 ) without thrombosis , embolism serious adverse event subject currently participate drug medical device clinical study reach primary endpoint ; childbearing age woman whose pregnancy test intervention operation negative , lactate mother ; subject renal function insufficiency ( serum creatinine &gt; 2.5mg / dL renal dialysis ) ; subject know allergy contraindication contrast agent , paclitaxel , heparin , antiplatelet , anticoagulant thrombolytic agent ; subject plan major amputation ( metatarsal level ) ; stroke subject within 3 month stroke subject severe hemiplegia aphasia associate sequelaes 3 month intervention operation ; subject acute myocardial infarction , thrombolytic therapy angina within 30 day intervention operation ; subject whose target lesion limb gangrene ( gangrene range metatarsophalangeal joint ) ; target lesion stenosis occlusion prior treat scaffold implantation , DEB , ordinary balloon catheter bypass graft ; lesion /or occlusion locate extend popliteal artery ankle joint ; subject require intervention bilateral low limb ; stenosis lesion ipsilateral femoral artery ipsilateral popliteal artery diameter stenosis ≥50 % untreated intervention operation ; ipsilateral femoral artery ipsilateral popliteal artery single adjacent lesion length ≥15cm , ipsilateral femoral artery ipsilateral popliteal artery multiple lesion one multiple lesion length ≥10cm occlusion ; adjacent lesion : 1 ) interval 30 mm , 2 ) treat single lesion ; multiple lesion : 1 ) interval 30 mm , 2 ) need treat multiple lesion ; residual stenosis still ≥30 % , even length &lt; 15cm stenosis ≥50 % single adjacent lesion ipsilateral femoral artery ipsilateral popliteal artery treat , lesion length &lt; 10cm stenosis ≥50 % multiple lesion ipsilateral femoral artery ipsilateral popliteal artery treat ; DES /or DEB use inflow vessel lesion treatment ; subject patency vessel ankle artery intervention operation ; target vessel aneurysm ; acute subacute thrombosis target vessel ; angiography show severe calcification target lesion ( contrast injection digital subtraction angiography , intensive annular calcification make target lesion expansion / calcification within target lesion locate either side vessel wall whose continuous length 5cm ) ; lesion guild wire pas ; subject need treat thrombus endarterectomy , percutaneous transluminal plaque circumcision laser treatment device indicate intraoperative angiography ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>drug elute balloon</keyword>
	<keyword>arterial vasculature knee</keyword>
</DOC>